http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103405384-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_16800ae1a23b3c4c7e6c2720109281c7 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195 |
| filingDate | 2013-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2226190ae35fdd026869c90e0aeaa868 |
| publicationDate | 2015-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103405384-B |
| titleOfInvention | Pharmaceutical composition of tranexamic acid |
| abstract | The invention belongs to the technical field of medicines, discloses a pharmaceutical composition of tranexamic acid, and particularly relates to a pharmaceutical composition containing tranexamic acid and organic acid. The pharmaceutical composition can be prepared into injection; the high-temperature and high-light tests show that the impurities, namely, cycloolefin, aminomethylbenzoic acid and a Z-isomer, and the total impurities of the injection meet the quality requirements. A preparation prepared from the pharmaceutical composition has the advantages of high stability and low impurity content. |
| priorityDate | 2013-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.